AIP
TTOO

ARS Investment Partners’s T2 Biosystems, Inc TTOO Stock Holding History

ARS Investment Partners’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-21
Closed -$133K – 115
2020
Q2 		$133K Buy
+21
New +$89.2K 0.03% 70

Other funds holding TTOO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ARS Investment Partners's TTOO Position: Q3 2020 in Review

ARS Investment Partners sold out of T2 Biosystems, Inc (TTOO) in Q3 2020, closing a stake of 21 shares — an estimated $133K sold.

ARS Investment Partners first reported a position in TTOO in Q2 2020 and held it in 1 quarter. The position peaked at $133K in Q2 2020. 53 funds tracked by Wall St. Rank hold TTOO as of Q3 2020.

  • ARS Investment Partners reported no remaining T2 Biosystems, Inc position as of Q3 2020 after selling out during the quarter.
  • ARS Investment Partners sold 21 T2 Biosystems, Inc shares in Q3 2020, an estimated $133K.
  • ARS Investment Partners first reported a position in T2 Biosystems, Inc in Q2 2020 and held it in 1 quarter.
  • ARS Investment Partners's T2 Biosystems, Inc position peaked at $133K in Q2 2020.
  • 53 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q3 2020.

Based on ARS Investment Partners's 13F filing for Q3 2020, filed 12 Nov 2020.